Martin Falck in the Eskeland group, recently presented a project that is running within the PharmaTox research environment at the 14th National Stem Cell Networking Conference here in Oslo. The title of the presentation was "Human Embryonic stem cells as a model for paracetamol induced epigenetic dysregulation".
The presentation was an description of the in vitro studies that is currently being done, utilizing human embryonic stem cells in a neural developmental model, in an attempt to explain why prenatal exposure to paracetamol can increase the risk of ADHD. The connection between paracetamol and ADHD symtoms has been a hot topic in the news lately so it is important for us to find out more about the biology and potential mechanisms underlying it.
This project is shared with PhD student Mari Spildrejorde and research engineer Magnus Leithaug, supervised by Ragnhild Eskeland and Robert Lyle. It is in collaboration with several groups within the PharmaTox Strategic Research Initiative and is mainly carried out at the University of Oslo and the Oslo University Hospital.
Photo: private